Literature DB >> 24655331

Gonadal and uterine function in female survivors treated by chemotherapy, radiotherapy, and/or bone marrow transplantation for childhood malignant and non-malignant diseases.

F Beneventi1, E Locatelli, G Giorgiani, M Zecca, F Locatelli, C Cavagnoli, M Simonetta, S Bariselli, B Negri, A Spinillo.   

Abstract

OBJECTIVE: To evaluate gonadal function and uterine volume in a cohort of female survivors treated by chemotherapy, radiotherapy, and/or stem cell transplantation (SCT) for childhood malignant and non-malignant diseases.
DESIGN: An observational study.
SETTING: S. Matteo Hospital, Pavia, Italy. POPULATION: A cohort of 135 female survivors.
METHODS: A clinical, hormonal, and ultrasonographic evaluation. Thirty-three patients (24%) had non-malignant haematologic diseases (thalassaemia or sickle cell anaemia), 68 (50%) had leukaemia, 23 (17%) had lymphomas, and 11 (8%) had solid tumours. In total, 106 patients had received SCT, preceded by a conditioning regimen. MAIN OUTCOME MEASURES: Anti-Müllerian hormone (AMH) and Inhibin-B, and uterine volume.
RESULTS: The median concentrations of AMH and Inhibin-B in the entire cohort were 0.12 ng/ml (interquartile range, IQR, 0.1-0.5 ng/ml) and 3.5 pg/ml (IQR 0.1-13.2 pg/ml), respectively. In a stepwise ordered logistic regression analysis, conventional chemotherapy for the treatment of malignancies, as opposed to total body irradiation (TBI), was the only oncologically significant predictor of increased AMH levels (OR 4.8, 95% CI 1.9-12, P < 0.001). Conditioning treatment before or after menarche did not influence AMH concentrations (P = 0.24). The best predictor of reduced uterine volume was TBI during the preparation for the allograft (OR 3.5, 95% CI 1.4-8.4, P = 0.006). Increasing age at treatment (OR 0.86, 95% CI 0.77-0.95, P = 0.04), chemotherapy, as opposed to other treatments (OR 0.09, 95% CI 0.03-0.28, P < 0.001), and solid tumours as opposed to either leukaemia/lymphomas or non-malignant diseases (OR 0.2, 95% CI 0.07-0.56, P = 0.002) were associated with larger uterine volumes.
CONCLUSIONS: Conditioning therapies for SCT, including TBI, had the worst effects on uterine volume and gonadal reserve. Increasing age at treatment and conventional chemotherapy were associated with less detrimental effects on uterine volume.
© 2014 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Antineoplastic treatments; gonadal and uterine function

Mesh:

Year:  2014        PMID: 24655331     DOI: 10.1111/1471-0528.12715

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  7 in total

1.  Reduced serum levels of anti-Müllerian hormone in females with inherited bone marrow failure syndromes.

Authors:  Martha M Sklavos; Pamela Stratton; Neelam Giri; Blanche P Alter; Sharon A Savage; Ligia A Pinto
Journal:  J Clin Endocrinol Metab       Date:  2014-11-18       Impact factor: 5.958

Review 2.  Ovarian and Uterine Functions in Female Survivors of Childhood Cancers.

Authors:  Ozgur Oktem; Samuel S Kim; Ugur Selek; Glenn Schatmann; Bulent Urman
Journal:  Oncologist       Date:  2017-11-20

Review 3.  Endocrine Disorders in Childhood Cancer Survivors Treated with Haemopoietic Stem Cell Transplantation.

Authors:  Christina Wei; Assunta Albanese
Journal:  Children (Basel)       Date:  2014-06-23

4.  Primary amenorrhea after bone marrow transplantation and adjuvant chemotherapy misdiagnosed as disorder of sex development: A case report.

Authors:  He Huang; Qinjie Tian
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

5.  Clinical summary guide: reproduction in women with previous abdominopelvic radiotherapy or total body irradiation.

Authors:  G Rozen; P Rogers; S Chander; R Anderson; O McNally; M Umstad; A Winship; K Hutt; W T Teh; A Dobrotwir; R Hart; W Ledger; K Stern
Journal:  Hum Reprod Open       Date:  2020-10-25

Review 6.  Maximizing the clinical utility of antimüllerian hormone testing in women's health.

Authors:  Benjamin Leader; Valerie L Baker
Journal:  Curr Opin Obstet Gynecol       Date:  2014-08       Impact factor: 1.927

Review 7.  The role of antimullerian hormone in assessing ovarian damage from chemotherapy, radiotherapy and surgery.

Authors:  Queenie Ho Yan Wong; Richard A Anderson
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-12       Impact factor: 3.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.